In a recently published landmark phase III study in patients with overweight or obesity (STEP 1), greater reductions in body weight were observed after 68 weeks of treatment with once-weekly semaglutide 2.4 mg vs
A reduced incretin effect mediated by the rs7903146 variant in the TCF7L2 gene is an early marker of -cell dysfunction in obese youth
Erratum in: J Am Coll Cardiol 2012;59(24):2306 52.Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al
This balance supports steady energy and more effective fat burning
Which compound fits which goals After examining the clinical data, mechanisms, side effects, and availability, the question becomes practical
We want to see if our current protocol is decreasing postoperative nausea and vomiting in this patient population, Strecker told Healio